$MYCB
My City Builders, Inc.

2021 Q2 Form 10-Q Financial Statement

#000164033421001673 Filed on July 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.48K $26.24K $4.380K
YoY Change -41.01% 248.01% -79.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.48K $26.24K $4.375K
YoY Change -41.01% 248.02% -79.8%
Operating Profit -$15.48K -$26.24K -$4.375K
YoY Change -41.01%
Interest Expense $14.63K -$41.85K -$70.61K
YoY Change -134.96% -38.74% -8.38%
% of Operating Profit
Other Income/Expense, Net -$14.63K -$41.85K -$70.61K
YoY Change -65.04% -38.74%
Pretax Income -$30.11K -$68.09K -$74.99K
YoY Change -55.78% -10.23% -24.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$30.11K -$68.09K -$74.99K
YoY Change -55.78% -73.5% -86.12%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$48.58K -$853.30 -$939.80
COMMON SHARES
Basic Shares Outstanding 77.47M shares 79.79M shares 79.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $760.00 $1.120K $1.400K
YoY Change -32.14% -46.92% -73.53%
Cash & Equivalents $755.00 $1.115K $1.400K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $755.00 $1.120K $1.400K
YoY Change -32.59% -46.92% -99.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $755.00 $1.120K $1.400K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $755.00 $1.120K $1.400K
YoY Change -32.59% -46.92% -99.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $76.17K $65.98K $52.22K
YoY Change 15.44% 91.36% 92.48%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $613.5K $554.2K $512.3K
YoY Change 10.72% 84.42% 120.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $922.0K $832.1K $764.2K
YoY Change 10.81% 41.09% 48.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $922.0K $832.1K $764.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $922.0K $832.1K $764.2K
YoY Change 10.81% 41.09% 48.66%
SHAREHOLDERS EQUITY
Retained Earnings -$12.78M
YoY Change
Common Stock $11.74M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$921.3K -$830.9K -$762.8K
YoY Change
Total Liabilities & Shareholders Equity $755.00 $1.120K $1.400K
YoY Change -32.59% -46.92% -99.24%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$30.11K -$68.09K -$74.99K
YoY Change -55.78% -73.5% -86.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$90.00 -$290.00 -$220.00
YoY Change -68.97% -90.91% -96.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -90.00 -290.0 -220.0
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -90.00 -290.0 -220.0
YoY Change -68.97% -90.91% -96.65%
FREE CASH FLOW
Cash From Operating Activities -$90.00 -$290.00 -$220.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12781317 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12713081 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-921262 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-853026 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
755 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1025 USD
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56808953 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
755 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1025 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
755 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1025 USD
CY2021Q2 us-gaap Assets
Assets
755 USD
CY2020Q3 us-gaap Assets
Assets
1025 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
76166 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72576 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
212816 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
193316 USD
CY2021Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
613535 USD
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
568659 USD
CY2021Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2020Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
922017 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
854051 USD
CY2021Q2 us-gaap Liabilities
Liabilities
922017 USD
CY2020Q3 us-gaap Liabilities
Liabilities
854051 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56808953 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79792286 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
56809 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
79792 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11683246 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11660263 USD
CY2021Q2 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2020Q3 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2021Q2 us-gaap Revenues
Revenues
0 USD
CY2020Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-68088 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
285 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
270 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
935 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
15390 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
25956 USD
us-gaap Professional Fees
ProfessionalFees
23090 USD
us-gaap Professional Fees
ProfessionalFees
33894 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
15480 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
26241 USD
us-gaap Operating Expenses
OperatingExpenses
23360 USD
us-gaap Operating Expenses
OperatingExpenses
34829 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15480 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26241 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23360 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-34829 USD
CY2021Q2 jrvs Interest And Accretion On Convertible Note
InterestAndAccretionOnConvertibleNote
-14630 USD
CY2020Q2 jrvs Interest And Accretion On Convertible Note
InterestAndAccretionOnConvertibleNote
-41847 USD
jrvs Interest And Accretion On Convertible Note
InterestAndAccretionOnConvertibleNote
-44876 USD
jrvs Interest And Accretion On Convertible Note
InterestAndAccretionOnConvertibleNote
-183074 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14630 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-41847 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44876 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-183074 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30110 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68088 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68236 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-217903 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-30110 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-68088 USD
us-gaap Net Income Loss
NetIncomeLoss
-68236 USD
us-gaap Net Income Loss
NetIncomeLoss
-217903 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77468129 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79034594 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-853026 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-19063 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-872089 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-19063 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-891152 USD
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-30110 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-921262 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-613027 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-74826 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-687853 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-74989 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-762842 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-830930 USD
us-gaap Net Income Loss
NetIncomeLoss
-68236 USD
us-gaap Net Income Loss
NetIncomeLoss
-217903 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
44876 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
183074 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3590 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6394 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
19500 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
27700 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-270 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-735 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-270 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-735 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1025 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1850 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
755 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1115 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
22983 USD
us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">iMine Corporation (the “Company”) is a Nevada corporation incorporated on October 26, 2010, under the name Oconn Industries. The Company’s name was changed to Oconn Industries Corp. on February 16, 2012, to Diamante Minerals, Inc. on April 1, 2014 and to iMine Corporation on March 20, 2018. The change of name to iMine Corporation was effective through the merger of the Company’s wholly owned subsidiary, iMine Corporation, into the Company. The Company has one subsidiary, iMine Corporation, an Indiana corporation, which is inactive.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the SEC include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company.</p>
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
22983333 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79792286 shares

Files In Submission

Name View Source Status
0001640334-21-001673-index-headers.html Edgar Link pending
0001640334-21-001673-index.html Edgar Link pending
0001640334-21-001673.txt Edgar Link pending
0001640334-21-001673-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jrvs-20210430.xsd Edgar Link pending
jrvs-20210430_cal.xml Edgar Link unprocessable
jrvs-20210430_def.xml Edgar Link unprocessable
jrvs-20210430_lab.xml Edgar Link unprocessable
jrvs-20210430_pre.xml Edgar Link unprocessable
jrvs_10q.htm Edgar Link pending
jrvs_10q_htm.xml Edgar Link completed
jrvs_ex311.htm Edgar Link pending
jrvs_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending